نتائج البحث - Alan Fix

تنقيح النتائج
  1. 1
    Economic Impact of Lyme Disease

    Economic Impact of Lyme Disease حسب Xinzhi Zhang, Martin I. Meltzer, César Peña, Annette Hopkins, Lane Wroth, Alan Fix

    منشور في 2006
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Role of hepatitis C infection in chronic liver disease in Egypt.

    Role of hepatitis C infection in chronic liver disease in Egypt. حسب G. Thomas Strickland, Hanaa Elhefni, Tary Salman, Imam Waked, Mohamed Abdel-Hamid, Nabiel Mikhail, Gamal Esmat, Alan Fix

    منشور في 2002
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Comparison of Second- and Third-Generation Enzyme Immunoassays for Detecting Antibodies to Hepatitis C Virus

    Comparison of Second- and Third-Generation Enzyme Immunoassays for Detecting Antibodies to Hepatitis C Virus حسب Mohamed Abdel‐Hamid, Mai M. El-Daly, Sherif A. El‐Kafrawy, Nabiel Mikhail, G. Thomas Strickland, Alan Fix

    منشور في 2002
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Safety and immunogenicity of a parenterally administered rotavirus VP8 subunit vaccine in healthy adults

    Safety and immunogenicity of a parenterally administered rotavirus VP8 subunit vaccine in healthy adults حسب Alan Fix, Clayton Harro, Monica McNeal, Len Dally, Jorge Flores, George A. Robertson, John W. Boslego, Stanley Cryz

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Intrafamilial transmission of hepatitis C in Egypt

    Intrafamilial transmission of hepatitis C in Egypt حسب M.K. Mohamed, Mohamed Abdel‐Hamid, Nabiel Mikhail, Fatma Abdel-Aziz, Ahmed Medhat, Laurence S. Magder, Alan Fix, Thomas H. Strickland

    منشور في 2005
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey.

    Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey. حسب M Nafeh, Ahmed Medhat, Mohamed Shehata, Nabiel Mikhail, YoussefM Swifee, Mohamed Abdel-Hamid, Sheldon Watts, Alan Fix, G. Thomas Strickland, Wagida A. Anwar, Ismail Sallam

    منشور في 2000
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Cholera in Lima, Peru, Correlates with Prior Isolation of Vibrio cholerae from the Environment

    Cholera in Lima, Peru, Correlates with Prior Isolation of Vibrio cholerae from the Environment حسب Augusto A. Franco, Alan Fix, Ana Prada, Eduar Bravo Paredes, Juan Carlos Palomino, Anita C. Wright, J. A. Johnson, Robert McCarter, Humberto Guerra, J. Glenn Morris

    منشور في 1997
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial

    Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial حسب Michelle J. Groome, Anthonet Koen, Alan Fix, Nicola Page, Lisa Jose, Shabir A. Madhi, Monica McNeal, Len Dally, Iksung Cho, Maureen Power, Jorge Flores, Stanley Cryz

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Hepatitis C virus(HCV) infection in a community in the nile delta: Population description and HCV prevalence

    Hepatitis C virus(HCV) infection in a community in the nile delta: Population description and HCV prevalence حسب Fatma Abdel-Aziz, Mostafa Habib, Mostafa K. Mohamed, Mohamed Abdel‐Hamid, F Gamil, Salah Madkour, Nabiel Mikhail, David L. Thomas, Alan Fix, T. Strickland, Wagida A. Anwar, Ismail Sallam

    منشور في 2000
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Hepatitis C virus infection in a community in the Nile Delta: Risk factors for seropositivity

    Hepatitis C virus infection in a community in the Nile Delta: Risk factors for seropositivity حسب Mostafa Habib, Mostafa K. Mohamed, Fatma Abdel‐Aziz, Laurence S. Magder, Mohamed Abdel‐Hamid, F Gamil, Salah Madkour, Nabiel Mikhail, Wagida A. Anwar, G. Thomas Strickland, Alan Fix, Ismail Sallam

    منشور في 2001
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Data and Safety Monitoring of COVID-19 Vaccine Clinical Trials

    Data and Safety Monitoring of COVID-19 Vaccine Clinical Trials حسب Steven Joffe, Abdel G. Babiker, Susan S. Ellenberg, Alan Fix, Marie R. Griffin, Sally Hunsberger, Jorge Kalil, Myron M. Levine, Malegapuru W. Makgoba, Reneé H. Moore, Anastasios A. Tsiatis, Richard J. Whitley

    منشور في 2021
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge

    Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge حسب Clayton Harro, A. Louis Bourgeois, David A. Sack, Richard I. Walker, Barbara DeNearing, Jessica Brubaker, Nicole Maier, Alan Fix, Len Dally, Subhra Chakraborty, John D. Clements, Ingelise Saunders, Michael J. Darsley

    منشور في 2019
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial

    Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial حسب Michelle J. Groome, Lee Fairlie, Julie Morrison, Alan Fix, Anthonet Koen, Maysseb Masenya, Lisa Jose, Shabir A. Madhi, Nicola Page, Monica McNeal, Len Dally, Iksung Cho, Maureen Power, Jorge Flores, Stanley Cryz

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Active Surveillance for Acute Viral Hepatitis in Rural Villages in the Nile Delta

    Active Surveillance for Acute Viral Hepatitis in Rural Villages in the Nile Delta حسب Fatma Abdel Salam Meky, Sonia Stoszek, M. Abdel Hamid, Samy Selim, Asrul Abdul Wahab, Nabiel Mikhail, Sherif A. El‐Kafrawy, Mai M. El-Daly, M. Kamal, Samar M. Sharaf, M.K. Mohamed, Ronald E. Engle, Suzanne U. Emerson, Robert H. Purcell, Alan Fix, G. Thomas Strickland

    منشور في 2006
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial

    Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controll... حسب Firdausi Qadri, Marjahan Akhtar, Taufiqur Rahman Bhuiyan, Mohiul Islam Chowdhury, Tasnuva Ahmed, Tanzeem Ahmed Rafique, Arifuzzaman Khan, Sadia Rahman, Farhana Khanam, Anna Lundgren, Gudrun Wiklund, Joanna Kaim, Madeleine Löfstrand, Nils Carlin, A. Louis Bourgeois, Nicole Maier, Alan Fix, Thomas F. Wierzba, Richard I. Walker, Ann–Mari Svennerholm

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in The Gambia: a phase 3, double-blind, randomised controlled trial

    Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants... حسب Magnus Ochoge, Ahmed Futa, Ama Umesi, Lucy Affleck, Larry Kotei, Baboucarr Daffeh, Ebrima Saidy-Jah, Anna Njie, Oluwafemi Temitayo Oyadiran, Bassey Edem, Musa Jallow, Edrissa Jallow, Simon Donkor, Erman Tritama, Talha Abid, Kathryn A V Jones, Bernardo A. Mainou, John Konz, Alan Fix, Chris Gast, Ed Clarke

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials

    Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical tri... حسب Xavier Sáez‐Llorens, Ananda S Bandyopadhyay, Christopher Gast, Tirza De León, Rodrigo DeAntonio, José Jimeno, Maria Isabel Caballero, Gabriela Aguirre, M. Steven Oberste, William C. Weldon, Jennifer L. Konopka‐Anstadt, John F. Modlin, Novilia Sjafri Bachtiar, Alan Fix, John Konz, Ralf Clemens, Sue Ann Costa Clemens, Ricardo Rüttimann

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analyses

    Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized,... حسب Marjahan Akhtar, Mohiul Islam Chowdhury, Taufiqur Rahman Bhuiyan, Joanna Kaim, Tasnuva Ahmed, Tanzeem Ahmed Rafique, Arifuzzaman Khan, Sadia Rahman, Farhana Khanam, Yasmin Ara Begum, Mir Z. Sharif, Laila N. Islam, Nils Carlin, Nicole Maier, Alan Fix, Thomas F. Wierzba, Richard I. Walker, A. Louis Bourgeois, Ann–Mari Svennerholm, Firdausi Qadri, Anna Lundgren

    منشور في 2018
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials

    Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials حسب Ilse De Coster, Isabel Leroux‐Roels, Ananda S Bandyopadhyay, Christopher Gast, Kanchanamala Withanage, Katie Steenackers, Philippe De Smedt, Annelies Aerssens, Geert Leroux‐Roels, M. Steven Oberste, Jennifer L. Konopka‐Anstadt, William C. Weldon, Alan Fix, John Konz, Rahnuma Wahid, John F. Modlin, Ralf Clemens, Sue Ann Costa Clemens, Novilia Sjafri Bachtiar, Pierre Van Damme

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine: 2 Randomized Clinical Trials

    Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine:... حسب Christopher Gast, Ananda S Bandyopadhyay, Xavier Sáez‐Llorens, Tirza De León, Rodrigo DeAntonio, José Jimeno, Gabriela Aguirre, Larin McDuffie, Elizabeth Coffee, Demetrius L. Mathis, M. Steven Oberste, William C. Weldon, Jennifer L. Konopka‐Anstadt, John F. Modlin, Novilia Sjafri Bachtiar, Alan Fix, John Konz, Ralf Clemens, Sue Ann Costa Clemens, Ricardo Rüttimann

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: